@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L84LC1DP-C
  skos:prefLabel "Pregnadienes"@en, "Prégnadiènes"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-FXZRT2LX-H .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-GRH5ZVG6-2
  skos:prefLabel "Mineralocorticoid Receptor Antagonists"@en, "Antagonistes des récepteurs des minéralocorticoïdes"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FXZRT2LX-H
  skos:hiddenLabel "Soldactone"@en, "Potassium Canrenoate"@en, "Spiroctan"@en, "Kalium-Can.-Ratiopharm"@en, "SC14266"@fr, "Soludactone"@en, "Canrénoate de potassium"@fr, "SC-14266"@fr, "SC-14266"@en, "Canrenoate Potassium"@en ;
  a mesh:Descriptor, skos:Concept ;
  mesh:allowableQualifier jvr:-THHNVC7V-3, jvr:-BT300B3G-Q, jvr:-NKM836P1-M, jvr:-G30ZJ446-J, jvr:-NB0XHT3S-N, jvr:-M63HSDM7-1, jvr:-G4R176S9-J, jvr:-T9HQD7ST-J, jvr:-W6SQV79N-S, jvr:-S0CS1X5R-5, jvr:-SBNWSM1T-R, jvr:-XV06LPML-W, jvr:-WK5F724J-1, jvr:-FWD2BGQ0-9, jvr:-H7K65Q8S-Z, jvr:-CB30NGKB-3, jvr:-D0F21513-5, jvr:-NFTHND7Q-8, jvr:-L6C0XPHT-4, jvr:-R3QWLHRG-V, jvr:-HQRFT0C6-B, jvr:-NHL3D2X0-S, jvr:-R0ZCQ8X6-J, jvr:-Q3979798-W, jvr:-TJHVZCRZ-0 ;
  dc:created "1974-11-11"^^xsd:date ;
  skos:altLabel "4138-96-9 (Canrenoic Acid)"@fr, "4138-96-9 (Canrenoic Acid)"@en, "2181-04-6 (Canrenoate Potassium)"@fr, "2181-04-6 (Canrenoate Potassium)"@en, "M671F9NLEA"@fr, "M671F9NLEA"@en, "17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic Acid"@en, "87UG89VA9K"@fr, "87UG89VA9K"@en ;
  dc:established "1991-01-01"^^xsd:date ;
  skos:prefLabel "Acide canrénoïque"@fr, "Canrenoic Acid"@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D002191> ;
  mesh:pharmacologicalAction jvr:-GRH5ZVG6-2 ;
  skos:inScheme jvr: ;
  skos:definition "A synthetic pregnadiene derivative with anti-aldosterone activity."@en ;
  skos:broader jvr:-L84LC1DP-C ;
  dc:modified "2017-05-24"^^xsd:date .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .